Advertisement
Screener

INMED PHARMACEUTICALS INC. (INM) Form DEFA14A: Additional definitive proxy soliciting materials

1.8 / 5 stars · 22/62 Roast Me

Add as a preferred source on Google

INMED PHARMACEUTICALS INC. Form DEFA14A: Additional definitive proxy soliciting materials

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-11-03: Form DEFA14A; Description DEFINITIVE ADDITIONAL MATERIALS; Document ea0263038-defa14a_inmed.htm.
  • 2025-05-29: Form DEFA14A; Description DEFINITIVE ADDITIONAL MATERIALS; Document ea0243555-defa14a_inmed.htm.
  • 2024-10-28: Form DEFA14A; Description ADDITIONAL DEFINITIVE PROXY MATERIALS; Document ea0218812-02.htm.
  • 2023-10-27: Form DEFA14A; Description ADDITIONAL MATERIALS; Document defa14a1023_inmedpharma.htm.
FiledFormPeriod of reportDescriptionDocument
2025-11-03DEFA14ADEFINITIVE ADDITIONAL MATERIALSea0263038-defa14a_inmed.htm
2025-05-29DEFA14ADEFINITIVE ADDITIONAL MATERIALSea0243555-defa14a_inmed.htm
2024-10-28DEFA14AADDITIONAL DEFINITIVE PROXY MATERIALSea0218812-02.htm
2023-10-27DEFA14AADDITIONAL MATERIALSdefa14a1023_inmedpharma.htm
2022-10-28DEFA14ADEFINITIVE ADDITIONAL MATERIALSea167719-defa14a_inmed.htm
2021-10-28DEFA14ADEFINITIVE ADDITIONAL MATERIALSea149498-defa14a_inmed.htm

Similar stocks

Stock NameCountryMarket CapPE Ratio
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
EXICURE, INC. (XCUR)United States$0.008B-1.54
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
SOLIGENIX, INC. (SNGX)United States$0.008B
Imunon, Inc. (IMNN)United States$0.008B-0.56
SYNLOGIC, INC. (SYBX)United States$0.007B
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63
Advertisement